REDUCEDT+30
Feeley Kevin
GeneDx Holdings Corp · NASDAQ
−586 sh · $55.2K
Filed 18 Sept 2026SEC Form 4view source
ARK Investment Management
13F filer
$110.5M
1,610,189 sh
BlackRock
13F filer
$24.2M
924,569 sh
Renaissance Technologies
13F filer
$9.9M
153,716 sh
Polen Capital Management
13F filer
$5.0M
77,419 sh
Two Sigma Investments
13F filer
$670.9K
10,447 sh
Stueland Katherine
US insider
$300.8K
11,104 sh
Feeley Kevin
US insider
$106.8K
4,991 sh
Fuchs Thomas
US insider
—
1,146 sh
Feeley Kevin
GeneDx Holdings Corp · NASDAQ
−586 sh · $55.2K
Feeley Kevin
GeneDx Holdings Corp · NASDAQ
−52 sh · $5.0K
Stueland Katherine
GeneDx Holdings Corp · NASDAQ
−148 sh · $14.1K
Fuchs Thomas
GeneDx Holdings Corp · NASDAQ
+1,146 sh
Feeley Kevin
GeneDx Holdings Corp · NASDAQ
+7,197 sh
Stueland Katherine
GeneDx Holdings Corp · NASDAQ
−4,141 sh · $406.9K
Stueland Katherine
GeneDx Holdings Corp · NASDAQ
+18,750 sh
Stueland Katherine
GeneDx Holdings Corp · NASDAQ
−1,648 sh · $155.3K
Feeley Kevin
GeneDx Holdings Corp · NASDAQ
−541 sh · $52.4K
Stueland Katherine
GeneDx Holdings Corp · NASDAQ
−3,039 sh · $300.8K